Kanvas Biosciences announced a $48 million Series A funding round, which will support a clinical trial later this year for the company’s lead cancer immunotherapy treatment.
Andrew Karolyi, dean of the Cornell SC Johnson College of Business, and colleagues found that even the least-successful U.S. serial acquirers will continue to make deals, persisting in spite of less-than-stellar announcement-day returns.
The 2026 Econometric Society Interdisciplinary Frontier: Economics and AI+Machine Learning Meeting will feature keynote talks, a panel discussion, and presentations from some of the sharpest minds in economics and AI.
New research from the Cornell SC Johnson College of Business reveals that pressure to meet earnings targets may push companies to drop weak products and focus on what they do best.